EyePoint Pharmaceuticals Inc (PSDV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert is an injectable, miniaturized, sustained-release drug delivery system, used for the treatment of chronic diseases of the back of the eye. EyePoints iluvien is an injectable, non-erodible, intravitreal implant for the treatment of DME. The company provides drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. It operates in the US and the UK. pSivida is headquartered in Watertown, Massachusetts, the US.

EyePoint Pharmaceuticals Inc (PSDV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
EyePoint Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
pSivida and Nicox Enter into Agreement 13
pSivida Enters into Agreement with Major Global Pharmaceutical Company 14
Licensing Agreements 15
Ocumension Therapeutics Enters into Licensing Agreement with EyePoint Pharma 15
Equity Offering 16
EyePoint Pharma Plans to Raise up to USD75 Million in Public Offering of Securities 16
EyePoint Pharma Raises USD28.9 Million in Private Placement in Shares upon Exercise of Warrants 17
EyePoint Pharma Plans to Raise Funds through Public Offering of Shares 18
EyePoint Pharma to Raise USD25.5 Million in Private Placement in Second Tranche of Units 19
EyePoint Pharma Raises USD9.5 Million in Private Placement of Securities 20
EyePoint Pharma Raises USD0.5 Million in Private Placement of Securities 21
pSivida Plans to Raise Upto USD20 Million in Public Offering of Shares 22
pSivida Raises USD17.8 Million in Public Offering of Shares 23
pSivida Raises USD7 Million in Private Placement of Shares 25
pSivida Announces Private Placement Of Shares For US$19 Million 26
pSivida Completes Public Offering Of Shares For US$10.8 Million 27
pSivida Completes Private Placement Of Units For US$5.4 Million 28
Acquisition 29
pSivida Acquires Icon Bioscience 29
EyePoint Pharmaceuticals Inc - Key Competitors 31
EyePoint Pharmaceuticals Inc - Key Employees 32
EyePoint Pharmaceuticals Inc - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Financial Announcements 34
Nov 06, 2018: EyePoint Pharmaceuticals reports fiscal first quarter 2019 financial results and highlights recent clinical and operational developments 34
Sep 12, 2018: EyePoint Pharmaceuticals reports fiscal 2018 fourth quarter & full year financial results and highlights recent progress 36
May 08, 2018: EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results 39
Feb 07, 2018: pSivida Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines 41
Nov 07, 2017: pSivida Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution 42
Sep 11, 2017: pSivida Achieves Significant Milestones Throughout FY 2017; Reports Fourth Quarter and Fiscal 2017 Results 43
May 04, 2017: pSivida Reports Fiscal 2017 Third Quarter Results; Key Milestones on Track 44
May 04, 2017: pSivida Reports Fiscal 2017 Third Quarter Results 45
May 04, 2017: pSivida Q3 net loss increases 46
Feb 07, 2017: pSivida Reports Fiscal 2017 Second Quarter and First Half Results 47
Corporate Communications 49
Nov 27, 2018: EyePoint Pharmaceuticals names Ron Honig, Esq., as SVP, general counsel & company secretary 49
Oct 30, 2018: EyePoint Pharmaceuticals appoints John Landis, Ph.D., M.S., to Board of Directors 50
Sep 10, 2018: EyePoint Pharmaceuticals names Goran Ando as Next Chairman of Board of Directors 51
Aug 15, 2018: Eyepoint Pharmaceuticals appoints John Weet, Ph.D., as SVP, regulatory affairs & quality 52
Jun 26, 2018: EyePoint Pharmaceuticals Names Goran Ando As Board Director 53
Jun 28, 2017: pSivida Enhances Board of Directors with Election of Veteran Healthcare Executive Kristine Peterson 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55

List Of Tables


EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
EyePoint Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
EyePoint Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
pSivida and Nicox Enter into Agreement 13
pSivida Enters into Agreement with Major Global Pharmaceutical Company 14
Ocumension Therapeutics Enters into Licensing Agreement with EyePoint Pharma 15
EyePoint Pharma Plans to Raise up to USD75 Million in Public Offering of Securities 16
EyePoint Pharma Raises USD28.9 Million in Private Placement in Shares upon Exercise of Warrants 17
EyePoint Pharma Plans to Raise Funds through Public Offering of Shares 18
EyePoint Pharma to Raise USD25.5 Million in Private Placement in Second Tranche of Units 19
EyePoint Pharma Raises USD9.5 Million in Private Placement of Securities 20
EyePoint Pharma Raises USD0.5 Million in Private Placement of Securities 21
pSivida Plans to Raise Upto USD20 Million in Public Offering of Shares 22
pSivida Raises USD17.8 Million in Public Offering of Shares 23
pSivida Raises USD7 Million in Private Placement of Shares 25
pSivida Announces Private Placement Of Shares For US$19 Million 26
pSivida Completes Public Offering Of Shares For US$10.8 Million 27
pSivida Completes Private Placement Of Units For US$5.4 Million 28
pSivida Acquires Icon Bioscience 29
EyePoint Pharmaceuticals Inc, Key Competitors 31
EyePoint Pharmaceuticals Inc, Key Employees 32
EyePoint Pharmaceuticals Inc, Subsidiaries 33

List Of Figures


EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
EyePoint Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
EyePoint Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

EyePoint Pharmaceuticals Inc (PSDV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 250 View Report

EyePoint Pharmaceuticals Inc (PSDV) - Medical Equipment - Deals and Alliances Profile

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 250 View Report

Constellation Pharmaceuticals Inc (CNST) - Financial and Strategic SWOT Analysis Review

Constellation Pharmaceuticals Inc (CNST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

EyePoint Pharmaceuticals Inc (PSDV) - Medical Equipment - Deals and Alliances Profile

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available